TGFB1 and fibrosis: Tissue fibrosis (associated with aberrant TGF-β signaling) and immune dysregulation worsen the disease and contribute to maladaptive phenotypic changes, which in later phases of the disease, might lead to an increased in HO-1 expression (and increased CO signaling).